Genopole is France’s leading biocluster with a special focus on life
sciences. Genopole’s campus harbours more than 80 innovative high tech life
science and biotech companies, public and private research units and well-known
universities and “Grandes Ecoles”. The Campus is located on one single site at Evry/Corbeil-Essonnes,
just south of Paris.
Genopole is soundly engaged to improve health and well-being of all
citizens by supporting highly innovative projects and start-ups. Since its creation in 1998, the biocluster
has been growing steadily and is currently home to 19 academic laboratories, 82
biotech companies, 25 shared use high – tech platforms and facilities and one
of the largest hospital of the Paris Region (from bench to bedside). Amongst
the sectors represented on the campus you find health-orientated topics like
drug development, therapeutics, diagnostics, medical device technologies,
e-Health, scientific instrumentation, bio-manufacturing and pharmaceuticals
services; but also different biotech sectors like industrial biotech,
food/agro-technologies, clean technologies and Synthetic Biology.
Genopole is one of the leading European bioclusters with over 2,300
employees. Its key figures are: 5 publicly traded companies; 503 M€ funds
raised by Genopole companies in the last 14 years; 41 products from the
regulatory preclinical phase to market lunch; and several international firms
such as New England Biolabs, Pharming, Santen SAS or Arianne Clinical.
Individual coaching and follow-up of
innovative projects and companies :
support from the business idea up to the successive funding rounds and/or
market access to promote and boost the creation of high-tech companies
skilled business managers with complementary backgrounds in both science and
business and with international experience to challenge the projects in the
creation phase, but also foster all competences necessary to set-up and to grow
your project or biotech company on the national and international level.
follow-up, training sessions and mentoring for selected projects covering all
the operational phases from business creation to development and market access.
High-level support to project leaders and
transform ideas into market-validated companies including business development,
fundraising, Industrial alliances and turnover generation
promote the strategic and financial development of the company on the
operate successfully with in- and out-licensing
facilitate access to high level technical platforms and scientific know-how of
maturate product, process, service development strategy, and commercialization
participate to on-site networking events with monthly business clubs for
promoting dialogue on key corporate issues.
Access to Resources and services at
laureates will have access to office space and laboratory facilities.
Services not included with the incubation (extra costs)
The French Tech Ticket laureates may
access 19 high tech platform available at Genopole such as microscopy
(electron –microscopy), imaging and cytometry, molecular biology or
structural biology platforms, etc. described on page 48 of the directory (http://www.genopole.fr/IMG/pdf/2015_directory_genopole.pdf).These technical platforms are shared
amongst the companies, projects and laboratories of Genopole and we will
support French Tech Ticket laureates in getting access to these platforms.
Our goal is to deliver the best support to
the laureates and facilitate their integration in the local and global